OVIDREL Side Effects

6590755-2 | Abortion Spontaneous, Pregnancy
on Jan 25, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with infertility female and was treated with Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?). Ovidrel dosage: Not Reported, Not Reported, Not. During the same period patient was treated with GONAL F (Not Reported, Not Reported, Not) (View Gonal-f Review and Gonal-f Label ).

6552883-7 | Multiple Pregnancy, Selective Abortion
Patient was taking Ovidrel (View Usage). Patient had the following side effects: multiple pregnancy, selective abortion on Jan 11, 2010 from CHINA Additional patient health information: Female patient , 28 years of age, was diagnosed with infertility (What is infertility?) and. Ovidrel dosage: 6500 Iu. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), P IN OIL (PROGESTERONE) (View P In Oil (progesterone) Review and P In Oil (progesterone) Label ).

6529019-1 | Ovarian Haemorrhage
Adverse event was reported on Oct 21, 2009 by a Female patient taking Ovidrel (View Usage) (Dosage: 250 Mcg) was diagnosed with infertility (What is infertility?) and. Location: KOREA, REPUBLIC OF , 35 years of age, After Ovidrel was administered, patient had the following side effects: ovarian haemorrhage. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), CETROTIDE (View Cetrotide Review and Cetrotide Label ).

6506896-1 | Abortion Spontaneous, Retained Placenta Or Membranes
on Dec 03, 2009 Female patient from UNITED STATES , 33 years of age, was diagnosed with infertility female and was treated with Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, retained placenta or membranes. Ovidrel dosage: . During the same period patient was treated with FOLLISTIM (View Follistim Review and Follistim Label ).


6310841-1 | Blood Prolactin Increased
on Jul 31, 2009 Female patient from UNITED STATES , 36 years of age, was diagnosed with infertility female and was treated with Ovidrel (View Usage). Patient had the following side effects: blood prolactin increased. Ovidrel dosage: 250 Mcg, Once, Subcutaneous. During the same period patient was treated with CLOMIPHENE CITRATE (CLOMIFENE) (View Clomiphene Citrate (clomifene) Review and Clomiphene Citrate (clomifene) Label ).

6124559-1 | Atrial Fibrillation
Patient was taking Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Mar 17, 2009 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 130.0 lb, was diagnosed with infertility (What is infertility?) and. Ovidrel dosage: 250 Ug Once Sq. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6076312-5 | Depression, Emotional Disorder, Hormone Level Abnormal
Adverse event was reported on Jan 28, 2009 by a Female patient taking Ovidrel (View Usage) (Dosage: 250 Mcg) was diagnosed with infertility female and. Location: UNITED STATES , 36 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: depression (What is depression?), emotional disorder, hormone level abnormal. Patient was hospitalized.

6058060-0 | Pituitary Tumour Benign
on Jan 27, 2009 Female patient from UNITED STATES , 36 years of age, was diagnosed with infertility female and was treated with Ovidrel (View Usage). Patient had the following side effects: pituitary tumour benign. Ovidrel dosage: 250 Mcg, Once Subcutaneous.

5801571-0 | Blood Human Chorionic Gonadotropin Increased, Off Label Use, Pain, Sports Injury, Testicular Neoplasm
on Jun 18, 2008 Male patient from UNITED STATES , 38 years of age, was diagnosed with off label use and was treated with Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: blood human chorionic gonadotropin increased, off label use, pain (What is pain?), sports injury, testicular neoplasm. Ovidrel dosage: 3 In 1 Weeks, 250 Mcg, 3 In 1 Weeks. During the same period patient was treated with TESTIM CREAM (TESTOSTERONE) (View Testim Cream (testosterone) Review and Testim Cream (testosterone) Label ).

5727753-4 | Abortion Spontaneous, Pregnancy
Patient was taking Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?) on Apr 16, 2008 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 112.0 lb, was diagnosed with infertility (What is infertility?) and. Ovidrel dosage: Once, Subcutaneous; Once, Subcutaneous. During the same period patient was treated with MENOPUR (View Menopur Review and Menopur Label ).

5647917-8 | Anaphylactic Reaction, Hypersensitivity
Adverse event was reported on Feb 19, 2008 by a Female patient taking Ovidrel (View Usage) (Dosage: 250 Mcg,) was diagnosed with infertility female and. Location: UNITED STATES , 34 years of age, Patient had the following side effects: anaphylactic reaction, hypersensitivity.

5520021-5 | Blood Human Chorionic Gonadotropin Increased, Inguinal Hernia, Injury, Testis Cancer
on Nov 02, 2007 Male patient from UNITED STATES , 38 years of age, was diagnosed with off label use and was treated with Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: blood human chorionic gonadotropin increased, inguinal hernia, injury, testis cancer. Ovidrel dosage: 250 Mcg, 3 In 1 Weeks. During the same period patient was treated with TESTIM CREAM (TESTOSTERONE) (View Testim Cream (testosterone) Review and Testim Cream (testosterone) Label ).

5519117-3 | Abdominal Pain, Effusion
on Oct 29, 2007 Female patient from FRANCE , 30 years of age, was treated with Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), effusion. Ovidrel dosage: . Patient was hospitalized.

5485596-3 | Blood Potassium Increased, Brain Oedema, Cerebral Ischaemia, Dehydration, Haematocrit Increased, Haemoconcentration, Haemoglobin Increased, Hepatic Enzyme Increased, Intracranial Pressure Increased
Patient was taking Ovidrel (View Usage). Patient had the following side effects: blood potassium increased, brain oedema, cerebral ischaemia, dehydration, haematocrit increased, haemoconcentration, haemoglobin increased, hepatic enzyme increased, intracranial pressure increased on Oct 04, 2007 from CANADA Additional patient health information: Female patient , 28 years of age, . Ovidrel dosage: . During the same period patient was treated with GONAL F (Subcutaneous Intramuscular) (View Gonal-f Review and Gonal-f Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ). Patient was hospitalized.

5478841-1 | Caesarean Section, Multiple Pregnancy, Streptococcal Identification Test Positive, Uterine Contractions Abnormal
Adverse event was reported on Sep 19, 2007 by a Female patient taking Ovidrel (View Usage) (Dosage: Subcutaneous) was diagnosed with ovulation induction and. Location: FRANCE , 33 years of age, After Ovidrel was administered, patient had the following side effects: caesarean section, multiple pregnancy, streptococcal identification test positive, uterine contractions abnormal. During the same period patient was treated with MENOPUR (View Menopur Review and Menopur Label ). Patient was hospitalized.

5423073-6 | Abortion Spontaneous, Menorrhagia
on Aug 10, 2007 Female patient from UNITED STATES , 30 years of age, was diagnosed with infertility female and was treated with Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, menorrhagia. Ovidrel dosage: . During the same period patient was treated with FOLLISTIM (View Follistim Review and Follistim Label ), LUPRON (View Lupron Review and Lupron Label ), MENOPUR (View Menopur Review and Menopur Label ).

5353537-5 | Jugular Vein Thrombosis, Metrorrhagia, Ovarian Hyperstimulation Syndrome, Twin Pregnancy
on May 29, 2007 Female patient from FRANCE , 31 years of age, weighting 121.3 lb, was diagnosed with in vitro fertilisation and was treated with Ovidrel (View Usage). Patient had the following side effects: jugular vein thrombosis, metrorrhagia, ovarian hyperstimulation syndrome, twin pregnancy. Ovidrel dosage: 250 Mcg, Once, Subcutaneous. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (See Image) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), ORGALUTRAN (GANIRELIX) (0.25 Mg, 1 In 1 Days, Subcutaneous) (View Orgalutran (ganirelix) Review and Orgalutran (ganirelix) Label ), ARDEPARIN (View Ardeparin Review and Ardeparin Label ), HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ). Patient was hospitalized.

5334145-9 | Jugular Vein Thrombosis, Metrorrhagia, Twin Pregnancy
Patient was taking Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: jugular vein thrombosis, metrorrhagia, twin pregnancy on May 14, 2007 from FRANCE Additional patient health information: Female patient , 31 years of age, weighting 121.3 lb, was diagnosed with in vitro fertilisation and. Ovidrel dosage: 250 Mg, Once, Subcutaneous. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (See Image) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), ORGALUTRAN (GANIRELIX) (0.25 Mg, 1 In 1 Days, Subcutaneous) (View Orgalutran (ganirelix) Review and Orgalutran (ganirelix) Label ), ARDEPARIN (View Ardeparin Review and Ardeparin Label ), HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ). Patient was hospitalized.

5330435-4 | Abdominal Pain, Abdominal Rebound Tenderness, Ascites, Cachexia, Culture Positive, Escherichia Infection, Hyperthermia, Inflammation, Ovarian Hyperstimulation Syndrome
Adverse event was reported on May 08, 2007 by a Female patient taking Ovidrel (View Usage) (Dosage: Once, Subcutaneous) was diagnosed with in vitro fertilisation and. Location: FRANCE , 28 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal rebound tenderness, ascites, cachexia, culture positive, escherichia infection, hyperthermia, inflammation, ovarian hyperstimulation syndrome. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (150 Iu) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), GONADORELIN INJ (Subcutaneous) (View Gonadorelin Inj Review and Gonadorelin Inj Label ). Patient was hospitalized.

5246127-6 | Ascites, Cachexia, Escherichia Infection, Hyperthermia, Nephrotic Syndrome, Ovarian Enlargement, Ovarian Hyperstimulation Syndrome, Pelvic Fluid Collection, Peritonitis
on Feb 09, 2007 Female patient from FRANCE , 28 years of age, weighting 110.2 lb, was diagnosed with in vitro fertilisation and was treated with Ovidrel (View Usage). Patient had the following side effects: ascites, cachexia, escherichia infection, hyperthermia, nephrotic syndrome, ovarian enlargement, ovarian hyperstimulation syndrome, pelvic fluid collection, peritonitis. Ovidrel dosage: Once, Subcutaneous. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (150 Iu) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), DECAPETYL (GONADORELIN /00486501/) (View Decapetyl (gonadorelin /00486501/) Review and Decapetyl (gonadorelin /00486501/) Label ). Patient was hospitalized.

5216751-5 | Ascites, Escherichia Infection, Hyperthermia, Inflammation, Nephrotic Syndrome, Ovarian Hyperstimulation Syndrome, Pelvic Haematoma, Peritonitis, Pleural Effusion
on Jan 08, 2007 Female patient from FRANCE , 28 years of age, weighting 88.18 lb, was diagnosed with in vitro fertilisation and was treated with Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: ascites, escherichia infection, hyperthermia, inflammation, nephrotic syndrome, ovarian hyperstimulation syndrome, pelvic haematoma, peritonitis, pleural effusion. Ovidrel dosage: Once, Subcutaneous. During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (150 Iu) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), GONADORELIN INJ (View Gonadorelin Inj Review and Gonadorelin Inj Label ). Patient was hospitalized.

5209700-7 | Abdominal Distension, Amenorrhoea, Blood Oestrogen Increased, Retching, Stomach Discomfort
Patient was taking Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, amenorrhoea, blood oestrogen increased, retching, stomach discomfort on Jan 23, 2006 from UNITED STATES Additional patient health information: Female patient , 24 years of age, was diagnosed with infertility female and. Ovidrel dosage: . Patient was hospitalized.

5034467-5 | Nasopharyngitis, Palpitations, Pulmonary Embolism
Adverse event was reported on Jun 06, 2006 by a Female patient taking Ovidrel (View Usage) (Dosage: ) was diagnosed with assisted fertilisation and. Location: FRANCE , 40 years of age, Patient had the following side effects: nasopharyngitis, palpitations, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CETROTIDE (View Cetrotide Review and Cetrotide Label ), FOLLITROPIN BETA (View Follitropin Beta Review and Follitropin Beta Label ), GONADOTROPINS (View Gonadotropins Review and Gonadotropins Label ). Patient was hospitalized.

4924707-2 | Abdominal Pain Lower, Hydronephrosis, Ovarian Enlargement, Renal Failure Acute, Ureteral Disorder, Ureteric Obstruction
on Feb 06, 2006 Female patient from NORWAY , 30 years of age, was diagnosed with in vitro fertilisation and was treated with Ovidrel (View Usage). After Ovidrel was administered, patient had the following side effects: abdominal pain lower, hydronephrosis, ovarian enlargement, renal failure acute, ureteral disorder, ureteric obstruction. Ovidrel dosage: . During the same period patient was treated with PUREGON (FOLLITROPIN BETA) (150 Iu, 1 In 1 Days; 125 Iu, 1 In 1 Days;) (View Puregon (follitropin Beta) Review and Puregon (follitropin Beta) Label ), SYNERELA (NAFARELIN ACETATE) (View Synerela (nafarelin Acetate) Review and Synerela (nafarelin Acetate) Label ), CRINONE (View Crinone Review and Crinone Label ). Patient was hospitalized.

4750058-5 | Dizziness, Dyspnoea, Heart Rate Increased, Palpitations, Tremor
on Aug 09, 2005 Female patient from NORWAY , 36 years of age, was diagnosed with in vitro fertilisation and was treated with Ovidrel (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dyspnoea, heart rate increased, palpitations, tremor. Ovidrel dosage: 250 Mcg, 1 In 1 Days. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), SUPRECUR (BUSERELIN ACETATE) (View Suprecur (buserelin Acetate) Review and Suprecur (buserelin Acetate) Label ). Patient was hospitalized.